Document Detail


Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis.
MedLine Citation:
PMID:  10188677     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Extracorporeal photochemotherapy (ECP) using UVA irradiation of enriched leukocytes in the presence of methoxsalen as a photoactivatable substrate has been employed for the treatment of several immunologically mediated disorders. OBJECTIVE: Our purpose was to determine the efficacy and safety of long-term ECP in the treatment of severe atopic dermatitis. METHODS: Fourteen patients with severe recalcitrant atopic dermatitis were treated with ECP in an open clinical trial at 2-week intervals. Disease activity was scored before each ECP cycle by means of a standardized protocol. RESULTS: A complete clinical remission was achieved in 4 patients (29%). Five patients (36%) experienced a substantial response with reduction of skin inflammation by at least 75%, whereas in one patient (7%) disease activity was reduced by more than 50%. Four patients were withdrawn from the study for unresponsiveness. No clinical signs of immunosuppression or other severe adverse events became evident. CONCLUSION: Long-term ECP may have significant beneficial effects on the course of atopic dermatitis and should therefore be considered as a treatment modality for patients suffering from severe and otherwise refractory atopic skin disease.
Authors:
B Prinz; S Michelsen; C Pfeiffer; G Plewig
Related Documents :
10887447 - Treating the patient with multiple cosmetic product allergies. a problem-oriented appro...
16371217 - Rebound phenomenon to systemic corticosteroid in atopic dermatitis.
478067 - Leucocyte migration inhibition in behçet's disease.
3127257 - An evaluation of topical mupirocin in moderately severe primary and secondary skin infe...
23428187 - Type a ulnar polydactyly of the hand: a classification system and clinical series.
12756157 - Improving guideline adherence: a randomized trial evaluating strategies to increase bet...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  40     ISSN:  0190-9622     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  1999 Apr 
Date Detail:
Created Date:  1999-04-15     Completed Date:  1999-04-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  577-82     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Ludwig-Maximilians-University, Munich, FRG.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Dermatitis, Atopic / drug therapy*
Drug Administration Schedule
Equipment Safety
Extracorporeal Circulation* / instrumentation
Female
Humans
Leukocytes / drug effects*
Long-Term Care
Male
Middle Aged
PUVA Therapy* / instrumentation
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A population-based survey on the use of artificial tanning devices in the Province of Québec, Canad...
Next Document:  Contact leukomelanosis induced by the leaves of Piper betle L. (Piperaceae): a clinical and histopat...